How does Cryptococcus get its coat?

Trends in Microbiology

Volumn 8, Issue 12, 2000, Pages 547-553

  Doering, Tamara L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; MANNAN; MANNOSE; MONOSACCHARIDE; OLIGOSACCHARIDE; POLYSACCHARIDE; VIRULENCE FACTOR;

BIOSYNTHESIS; CARBOHYDRATE ANALYSIS; CELL WALL; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; ELECTRON MICROSCOPY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CARBOHYDRATE SEQUENCE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0034544608     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(00)01890-4     Document Type: Review

References (75)

1. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates
2. Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha mating type
3. The G-protein β subunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans
4. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans
5. Virulence factors of Cryptococcus neoformans
6. Virulence factors of medically important fungi
7. Virulence factors of Cryptococcus neoformans
8. Cryptococcus neoformans: virulence and host defenses
9. Ultrastructural study of Cryptococcus neoformans by quick-freezing and deep-etching method
10. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release
11. Polysaccharide antigens of the capsule of Cryptococcus neoformans
12. Structural characterization of the galactoxylomannan of Cryptococcus neoformans CAP67
13. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network
14. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay
15. In vitro and in vivo stability of a Cryptococcus neoformans glucuronoxylomannan epitope that elicits protective antibodies
16. What makes Cryptococcus neoformans a pathogen?
17. Macrophage interactions with Cryptococcus neoformans
18. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection
19. Protective murine monoclonal antibodies to Cryptococcus neoformans
20. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice
21. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies
22. An unencapsulated variant of Cryptococcus neoformans
23. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans
24. Strains of Cryptococcus neoformans with defined capsular phenotypes
25. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence
26. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence
27. Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans
28. Isolation, characterization and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans
29. Biosynthesis of uridine diphosphate d-xylose. III. Uridine diphosphate d-glucose dehydrogenase of Cryptococcus laurentii
30. Biosynthesis of uridine diphosphate d-xylose. II. Uridine diphosphate d-glucuronate carboxy-lyase of Cryptococcus laurentii
31. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans
32. Cryptococcal UDP-glucose dehydrogenase: enzymic control of capsular biosynthesis
33. Xylosyltransferases from Cryptococcus laurentii
34. Mannosyltransferases from Cryptococcus laurentii
35. Uridine diphosphate D-xylose. Acceptor xylosyltransferase of Cryptococcus laurentii
36. Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans
37. A unique alpha-1,3, mannosyltransferase of the pathogenic fungus Cryptococcus neoformans
38. Studies of capsule synthesis of Cryptococcus neoformans
39. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide
40. Capsule synthesis by Cryptococcus neoformans
41. Regulation of cryptococcal polysaccharide by iron
42. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection
43. Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP
44. Cryptococcus neoformans STE12α regulates virulence but is not essential for mating
45. The STE12α homolog is required for haploid filamentation but largely dispensable for mating and virulence in Cryptococcus neoformans
46. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination
47. Facilitated isolation, purification and analysis of glucuronoxylomannan of Cryptococcus neoformans
48. Decomposition of the capsular polysaccharide of Cryptococcus neoformans 3723 by a soil microorganism
49. Genetic analysis of proteoglycan structure, function and metabolism
50. Non-encapsulated variant of Cryptococcus neoformans: surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide
51. Binding of cryptococcal polysaccharide to Cryptococcus neoformans
52. Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants
53. Biosynthesis and expression of cell-surface polysaccharides in Gram-negative bacteria
54. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation
55. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA
56. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans
57. Dominant selection system for use in Cryptococcus neoformans
58. Isolation of telomere-like sequences from Cryptococcus neformans and their use in high-efficiency transformation
59. Targeted gene replacement demonstrates that myristoyl-CoA:protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans
60. Construction of stable episomes in Cryptococcus neoformans
61. Characterization of the glyceraldehyde-3-phosphate gene and the use of its promoter for heterologous expression in Cryptococcus neoformans, a human pathogen
62. A glucan synthase FKS1 homolog in Cryptococcus neoformans is single copy and encodes an essential function
63. Topoisomerase I is essential in Cryptococcus neoformans: role in pathobiology and as an antifungal target
64. A novel episomal shuttle vector for transformation of Cryptococcus neoformans with the ccdB gene as a positive selection marker in bacteria
65. Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans
66. Diploid strains of the pathogenic basidiomycete Cryptococcus neoformans are thermally dimorphic
67. Fate of transforming DNA in pathogenic fungi
68. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes
69. Calcineurin is required for virulence of Cryptococcus neoformans
70. The Cryptococcus neoformans STE12a gene: a putative Saccharomyces cerevisiae STE12 homologue that is mating-type specific
71. Signal transduction cascades regulating mating, filamentation, and virulence in Cryptococcus neoformans
72. Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein
73. Ferric iron reduction by Cryptococcus neoformans